CGEN
COMPUGEN LTD
$2.02
-0.98%
$193.0M
No data for this timeframe.
Vol
Market Cap$193.0M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (91%)
Insider Activity0B / 11S
Insider Net $-$121.6K
Reddit Sentiment60° Warm
SEC Reports6
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. L3·CIK 0001119774·Prev Close $2.04
Recent Activity
Jun 9, 2026
SEC
Compugen's shelf registration statement on Form F-3 (File No. 333-295989) was declared effective by the SEC on June 8, 2
EFFECT — Impact 3/10
May 18, 2026
SEC
Compugen reported Q1 2026 results with revenue of $2.2M (vs $2.3M in Q1 2025) and net loss of $7.7M ($0.08/share) vs $7.
6-K — Impact 4/10
May 18, 2026
earnings_calendar
CGEN Q1 2026 Earnings Scheduled — 2026-05-18
Apr 27, 2026
SEC
Two insiders at Compugen (CGEN) sold shares totaling ~$22K after exercising stock options. The dollar amount represents
CLUSTER — Impact 2/10
Apr 24, 2026
Insider
Ophir Eran sold 5,000 shares
President and CEO @ $0.8292 ($4.1K)
Apr 24, 2026
Insider
Ophir Eran sold 5,000 shares
President and CEO @ $3.20 ($16.0K)
Apr 24, 2026
Insider
Ophir Eran sold 5,000 shares
President and CEO @ $0.00 ($0.00)
Price Targets
$4.60
+127.7% upside
Strong Buy
Current $2.02
Low $4.00
Median $4.00
High $6.00
5 analysts
$4.00
$6.00
Analyst Ratings
5Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 21, 2026 | Leerink Partners | MAINTAIN | Outperform → Outperform |
| Apr 7, 2026 | Lake Street | INITIATE | Buy |
| Jan 7, 2026 | HC Wainwright & Co. | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.09 ▼ -6.3% | $-0.10 — $-0.07 | -6% YoY | 2 |
| Next Q | $-0.09 ▼ -6.3% | $-0.10 — $-0.07 | -21% YoY | 2 |
| Current FY | $-0.34 ▼ -4.1% | $-0.38 — $-0.30 | -189% YoY | 2 |
| Next FY | $-0.36 ▼ -9.5% | $-0.42 — $-0.31 | -7% YoY | 2 |
Latest Reports
NEUTRAL
EFFECT
3/10
Compugen's shelf registration statement on Form F-3 (File No. 333-295989) was declared effective by the SEC on June 8, 2
Jun 9, 2026
NEUTRAL
6-K
4/10
Compugen reported Q1 2026 results with revenue of $2.2M (vs $2.3M in Q1 2025) and net loss of $7.7M ($0.08/share) vs $7.
May 18, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 24, 2026 | Ophir Eran | M | $4.1K |
| Apr 24, 2026 | Ophir Eran | SELL | $16.0K |
| Apr 24, 2026 | Ophir Eran | M | $0.00 |
| Apr 24, 2026 | Levine Zurit | M | $2.3K |
| Apr 24, 2026 | Levine Zurit | SELL | $6.4K |
Reddit Sentiment
60°
Warm
Bearish
Neutral
Bullish
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
2 unique insiders with 11 transactions. Net insider value: -$121.6K ($0.00 bought, $121.6K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 24, 2026 | Ophir Eran | President and CEO | M | 5,000 | $0.8292 | $4.1K |
| Apr 24, 2026 | Ophir Eran | President and CEO | SELL | 5,000 | $3.20 | $16.0K |
| Apr 24, 2026 | Ophir Eran | President and CEO | M | 5,000 | $0.00 | $0.00 |
| Apr 24, 2026 | Levine Zurit | SVP, Business Development | M | 2,000 | $1.15 | $2.3K |
| Apr 24, 2026 | Levine Zurit | SVP, Business Development | SELL | 2,000 | $3.20 | $6.4K |
| Apr 24, 2026 | Levine Zurit | SVP, Business Development | M | 2,000 | $0.00 | $0.00 |
| Apr 14, 2026 | Ophir Eran | President and CEO | M | 5,000 | $0.00 | $0.00 |
| Apr 14, 2026 | Levine Zurit | SVP, Business Development | M | 2,000 | $1.15 | $2.3K |
| Apr 14, 2026 | Ophir Eran | President and CEO | M | 5,000 | $0.8292 | $4.1K |
| Apr 14, 2026 | Ophir Eran | President and CEO | SELL | 5,000 | $2.90 | $14.5K |
| Apr 14, 2026 | Levine Zurit | SVP, Business Development | SELL | 2,000 | $2.80 | $5.6K |
| Apr 14, 2026 | Levine Zurit | SVP, Business Development | M | 2,000 | $0.00 | $0.00 |
| Apr 10, 2026 | Levine Zurit | SVP, Business Development | M | 1,125 | $0.8292 | $932.85 |
| Apr 10, 2026 | Levine Zurit | SVP, Business Development | SELL | 3,125 | $2.56 | $8.0K |
| Apr 10, 2026 | Levine Zurit | SVP, Business Development | M | 1,125 | $0.00 | $0.00 |
| Apr 10, 2026 | Levine Zurit | SVP, Business Development | M | 1,125 | $0.8292 | $932.85 |
| Apr 10, 2026 | Levine Zurit | SVP, Business Development | SELL | 3,125 | $2.56 | $8.0K |
| Apr 10, 2026 | Levine Zurit | SVP, Business Development | M | 1,125 | $0.00 | $0.00 |
| Apr 8, 2026 | Levine Zurit | SVP, Business Development | M | 4,375 | $0.8292 | $3.6K |
| Apr 8, 2026 | Levine Zurit | SVP, Business Development | SELL | 5,375 | $2.42 | $13.0K |
| Apr 8, 2026 | Levine Zurit | SVP, Business Development | M | 4,375 | $0.00 | $0.00 |
| Apr 7, 2026 | Levine Zurit | SVP, Business Development | M | 2,500 | $0.8292 | $2.1K |
| Apr 7, 2026 | Levine Zurit | SVP, Business Development | SELL | 2,500 | $2.30 | $5.8K |
| Apr 7, 2026 | Levine Zurit | SVP, Business Development | M | 2,500 | $0.00 | $0.00 |
| Apr 1, 2026 | Levine Zurit | SVP, Business Development | M | 2,500 | $0.00 | $0.00 |
| Apr 1, 2026 | Levine Zurit | SVP, Business Development | SELL | 3,500 | $2.20 | $7.7K |
| Apr 1, 2026 | Levine Zurit | SVP, Business Development | M | 2,500 | $0.8292 | $2.1K |
| Apr 1, 2026 | Ophir Eran | President and CEO | M | 5,625 | $0.00 | $0.00 |
| Apr 1, 2026 | Ophir Eran | President and CEO | SELL | 5,625 | $2.21 | $12.4K |
| Apr 1, 2026 | Ophir Eran | President and CEO | M | 5,625 | $0.8292 | $4.7K |
| Mar 26, 2026 | Levine Zurit | SVP, Business Development | M | 11,875 | $0.00 | $0.00 |
| Mar 26, 2026 | Levine Zurit | SVP, Business Development | SELL | 11,875 | $2.04 | $24.2K |
| Mar 26, 2026 | Levine Zurit | SVP, Business Development | M | 11,875 | $0.8292 | $9.8K |
6 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 6 neutral. Avg impact: 2.8/10.
NEUTRAL
EFFECT
3/10
Compugen's shelf registration statement on Form F-3 (File No. 333-295989) was declared effective by
Jun 9, 2026
NEUTRAL
6-K
4/10
Compugen reported Q1 2026 results with revenue of $2.2M (vs $2.3M in Q1 2025) and net loss of $7.7M
May 18, 2026
NEUTRAL
CLUSTER
2/10
Two insiders at Compugen (CGEN) sold shares totaling ~$22K after exercising stock options. The dolla
Apr 27, 2026
NEUTRAL
CLUSTER
2/10
Two corporate insiders at Compugen Ltd—CEO Ophir Eran and SVP Levine Zurit—sold shares in open-marke
Apr 15, 2026
NEUTRAL
144
3/10
Zurit Levine, an officer of Compugen Ltd, filed a Form 144 to notify intent to sell up to 2,000 ordi
Apr 13, 2026
NEUTRAL
CLUSTER
3/10
Compugen CEO Ophir Eran sold $12.4K of stock and exercised two tranches of options, one at zero cost
Apr 3, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (91% buy). Based on 11 analysts: 5 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$4.60 mean target
+127.7% upside
Strong Buy (1.00)
$4.00 Low
$6.00 High
| Metric | Value |
|---|---|
| Current Price | $2.02 |
| Target Low | $4.00 |
| Target Mean | $4.60 |
| Target Median | $4.00 |
| Target High | $6.00 |
| # Analysts | 5 |
| Recommendation | Strong Buy (1.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.09 | $-0.10 | $-0.07 | -6.3% | -6.3% | 0↑ 1↓ | $0.0B | 2.2% | 2 |
| Next Q 2026-09-30 |
$-0.09 | $-0.10 | $-0.07 | -21.4% | -6.3% | 0↑ 1↓ | $0.0B | -32.1% | 2 |
| Current FY 2026-12-31 |
$-0.34 | $-0.38 | $-0.30 | -189.5% | -4.1% | 0↑ 2↓ | $0.0B | -87.1% | 2 |
| Next FY 2027-12-31 |
$-0.36 | $-0.42 | $-0.31 | -7.3% | -9.5% | 0↑ 1↓ | $0.0B | 70.5% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.085 | |
| 7d ago | $-0.080 | -0.005 |
| 30d ago | $-0.080 | -0.005 |
| 60d ago | $-0.080 | -0.005 |
| 90d ago | $-0.080 | -0.005 |
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 2 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 21, 2026 | Leerink Partners | MAINTAIN | Outperform | Outperform |
| Apr 7, 2026 | Lake Street | INITIATE | — | Buy |
| Jan 7, 2026 | HC Wainwright & Co. | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 5 | 1 | 0 | 0 | 91% | |
| May 1, 2026 | 5 | 6 | 1 | 0 | 0 | 92% | |
| Apr 1, 2026 | 5 | 5 | 1 | 0 | 0 | 91% | |
| Mar 1, 2026 | 5 | 5 | 1 | 0 | 0 | 91% | |
| Feb 1, 2026 | 5 | 5 | 1 | 0 | 0 | 91% | |
| Jan 1, 2026 | 5 | 4 | 1 | 0 | 0 | 90% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
60°
Warm
Bearish
Neutral
Bullish
1 mentions
1 bullish
0 bearish
1 time period
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Mar 12, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
What’s your input?
▲ 1
💬 1
⚡ 0.5
May 18, 2026
earnings_calendar
CGEN Q1 2026 Earnings Scheduled — 2026-05-18
May 18, 2026
short_volume
Short Volume: CGEN — 58.8% short (0.3M / 0.6M)
Short: 346,875 | Exempt: 6,403 | TRF Vol: 589,492 | Short Ratio: 58.8% | Off-exchange volume (dark pool + OTC)
Apr 24, 2026
short_volume
Short Volume: CGEN — 61.4% short (0.4M / 0.6M)
Short: 360,658 | Exempt: 13 | TRF Vol: 587,674 | Short Ratio: 61.4% | Off-exchange volume (dark pool + OTC)
Apr 14, 2026
short_volume
Short Volume: CGEN — 63.0% short (0.3M / 0.5M)
Short: 323,586 | Exempt: 0 | TRF Vol: 513,969 | Short Ratio: 63.0% | Off-exchange volume (dark pool + OTC)
Mar 2, 2026
earnings_calendar
CGEN Q4 2025 Earnings After Market Close — 2026-03-02